PhUSE are please to welcome two keynote speakers to the PhUSE 2017 EU CSS.
Dr. Trish Groves
'Why Data Sharing from Clinical Trials Really Matters'
Dr Trish Groves trained in medicine and psychiatry before joining The BMJ in 1989. Trish is the Director of Academic Outreach and Advocacy for The BMJ, Editor-in-Chief on the online only journal and Honorary Deputy Editor of The BMJ.
She has published widely, particularly as a co-author of research reporting guidelines including the CONSORT 2010 statement on clinical trials.
Trish is currently exploring how the BMJ might help to build capabilities for health research in the low and middle income countries, and is editorial lead of BMJ's Research to Publication e-learnigng programme for health researchers.
Trish will explore the ethical and public health importance of clinical trial transparency and ask what we still need to do to change the culture.
'How PhUSE Collaborations Assist Regulatory Review'
Crystal Allard is a Special Assistant to the Director in the Office of Computational Science at the FDA/CDER.
She is the programme manager for all collaborations with OCS and also serves as the Programme Director for the OCS Data Validation Programe.
Crystal is an FDA liaison for the PhUSE Computational Science Steering and Planning Committees, and a founding member of the Emerging Trends & Technologies Working Group. Crystal has worked at the FDA since 2008 and at the OCS since 2012.
Crystal will highlight the places where PhUSE collaborations have effected positive change in the FDA regulatory review of market applications, and explore where PhUSE deliverables have impacted reviews and possible areas for future work.